Loading clinical trials...

Ga-68 MAA Distribution in PAE Patients | Clinical Trials | Clareo Health

WITHDRAWNEARLY Phase 1NCT04243824

Ga-68 MAA Distribution in PAE Patients

Purpose: The purpose of this study is to evaluate Ga-68 MAA distribution on PET/MRI after injection into the prostatic arteries in patients without prostate cancer who are being treated with prostate ...

Lead sponsor: University of North Carolina, Chapel Hill•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

NCT05574244 · Benign Prostatic Hyperplasia

RECRUITINGNA

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

NCT03297281 · Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction

RECRUITING

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

NCT07016620 · Benign Prostatic Hyperplasia (BPH)

RECRUITINGNA

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

NCT06312722 · Benign Prostatic Hyperplasia

RECRUITINGNA

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

NCT06817733 · Benign Prostatic Hyperplasia (BPH)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 15, 2021Terms

Trial snapshot

StatusWITHDRAWN

PhaseEARLY_PHASE1

Enrollment—

Start dateMay 2021

Last updatedJan 15, 2021

Condition

Benign Prostatic Hyperplasia

Locations shown

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Ga-68 MAA Distribution in PAE Patients

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

Trial snapshot

Condition

Locations shown

For caregivers